Toxicology and Applied Pharmacology · 2016 · 15 citations · 56 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionCancer ImmunosurveillanceCancer ImmunotherapyMalignant NeoplasmsMelanoma PharmacotherapyMetastatic Disease TreatmentTargeted Cancer TherapyBraf V600 MutationsImmunogenicity Of Tumor AntigensMetastasis SuppressionMetastatic Melanoma TreatmentOncogenic Braf SignalingTumor Antigen ImmunogenicityTumor Immunogenicity
56
Helen M. Berman · Nucleic Acids Research · 2000 · 39.8K citations
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
Paul Wan, Mathew J. Garnett, S. Mark Roe et al. · Cell · 2004 · 2.8K citations · Full text
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text
Medicine, Oncology, Pharmacotherapy +14